Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

NCT01493843

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • cCare Encinitas, California, United States
  • Kaiser Permanente - Oakland Oakland, California, United States
View all 120 locations
View Trial Details
Completed

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

NCT01999673

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Peregrine Pharmaceuticals Investigational Site Huntsville, Alabama, United States
  • Peregrine Pharmaceuticals Investigational Site Chandler, Arizona, United States
  • Peregrine Pharmaceuticals Investigational Site Glendale, Arizona, United States
  • Peregrine Pharmaceuticals Investigational Site Greenbrae, California, United States
View all 161 locations
View Trial Details
Completed

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

NCT03117335

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Bengbu medical college affiliated hospital Bengbu, Anhui, China
  • The first affiliated hospital, anhui medical university Hefei, Anhui, China
  • The second affiliated hospital, anhui medical university Hefei, Anhui, China
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
View all 37 locations
View Trial Details
Completed

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

NCT00622193

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Osler Medical Melbourne, Florida, United States
  • Augusta Oncology Associates Augusta, Georgia, United States
  • South Georgia Medical Center Valdosta, Georgia, United States
View all 33 locations
View Trial Details
Completed

A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

NCT01153984

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • County Hospital Alba; Oncology Alba Iulia, Romania
  • Institut of Oncology Al. Trestioreanu Bucharest; Oncology Bucharest, Romania
  • Institute Of Oncology Bucharest; Medical Oncology Bucharest, Romania
  • Spitalul de Boli Cronice Sf. Luca Bucharest, Romania
View Trial Details

Related conditions